Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

Clinical trial NCT00003838 · COMPLETED

Trial details

NCT number: NCT00003838
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myeloproliferative Disorders Acute Myelogenous Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndrome Acute Lymphoblastic Leukemia

Start date: 1999-04-15
Primary completion: 2018-12-14
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.